Download Citation
Article Source:
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults
Pillet S,
Couillard J,
Trépanier S,
Poulin JF,
Yassine-Diab B,
et al.
(2019)
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.
PLOS ONE 14(6): e0216533.
https://doi.org/10.1371/journal.pone.0216533